Auf dieser Seite
OVID Ovid Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$2,38
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,1852-Wochen-Tief
$3,1152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$440M
P/E
-7.5
EPS
$-0.74
Umsatz
$7M
Ihre Abzeichen
52W-Spanne
$1–$3
Analystenbewertung
BUY
Kursziel
$6
P/E
-7.5
ROE
-18.7%
Nettogewinnmarge
-2178.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
OVID Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.38
Marktkapitalisierung (MRQ)
$440M
P/E
-7.5
EPS
$-0.74
Umsatz
$7M
ROE
-18.7%
52W-Spanne
$1–$3
OVID Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$7M2020-12-31 → 2025-12-31
EPS$-0.742020-12-31 → 2023-12-31
Freier Cashflow$-38M2017-12-31 → 2025-12-31
Nettogewinnmarge-2178.9%2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | OVID | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -7.55-Jahres-Durchschnitt ≈-2.2 | ≈-2.2 | · | · | |
| P/S (TTM) | 277.85-Jahres-Durchschnitt ≈174.6 | ≈174.6 | 3.7 | Überbewertet | |
| K/B (MRQ) | 2.15-Jahres-Durchschnitt ≈1.6 | ≈1.6 | 3.0 | Unterbewertet | |
| Price / FCF (Kurs / FCF) | -10.45-Jahres-Durchschnitt ≈-2.7 | ≈-2.7 | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -10.45-Jahres-Durchschnitt ≈-2.7 | ≈-2.7 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 2.15-Jahres-Durchschnitt ≈1.5 | ≈1.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | OVID | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -3686.7%5-Jahres-Durchschnitt ≈-4839.2% | ≈-4839.2% | -47.4% | Schwach | |
| EBITDA-Marge (TTM) | -3681.4%5-Jahres-Durchschnitt ≈-4793.4% | ≈-4793.4% | -47.4% | Schwach | |
| Vorgewinnmarge (TTM) | -2178.9%5-Jahres-Durchschnitt ≈-4286.8% | ≈-4286.8% | -61.1% | Schwach | |
| Nettogewinnmarge (TTM) | -2178.9%5-Jahres-Durchschnitt ≈-4287.0% | ≈-4287.0% | -28.8% | Schwach | |
| ROA | -14.3%5-Jahres-Durchschnitt ≈2.6% | ≈2.6% | -14.3% | Im Einklang | |
| ROE | -18.7%5-Jahres-Durchschnitt ≈-12.1% | ≈-12.1% | -14.4% | Schwach | |
| ROIC | -32.5%5-Jahres-Durchschnitt ≈-18.4% | ≈-18.4% | -12.1% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | OVID | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 12.45-Jahres-Durchschnitt ≈12.5 | ≈12.5 | 10.4 | Starke Liquidität | |
| Quick Ratio | 1.65-Jahres-Durchschnitt ≈5.8 | ≈5.8 | 2.9 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | OVID | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 1181.3%5-Jahres-Durchschnitt ≈520.8% | ≈520.8% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 69.0%5-Jahres-Durchschnitt ≈-28.5% | ≈-28.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -10.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | OVID | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.4 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$315.3K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
37.4%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 18, 2026 | $-0.08 | $-0.12 | 35.2% |
| 31. März 2026 | Mai 13, 2026 | $-0.12 | $-0.12 | 2.2% |
| 31. Dezember 2025 | $0.06 | $-0.12 | 149.4% | |
| 30. September 2025 | $-0.17 | $-0.15 | -11.2% | |
| 30. Juni 2025 | $-0.06 | $-0.16 | 63.6% | |
| 31. März 2025 | $-0.14 | $-0.14 | -0.43% | |
| 31. Dezember 2024 | $-0.13 | $-0.17 | 23.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $7M | $566.0K | $392.0K | $2M | $208M | $13M | |
| R&D Expense | $26M | $37M | $29M | $25M | $47M | $63M | |
| SG&A Expense | $24M | $26M | $31M | $32M | $37M | $31M | |
| Operating Expenses | $50M | $62M | $60M | $57M | $84M | $94M | |
| Operating Income | $-42M | $-62M | $-59M | $-56M | $124M | $-81M | |
| Interest Income | $2M | $4M | $5M | · | · | · | |
| Other Non-op | $25M | $35M | $7M | $1M | $-45.7K | · | |
| Pretax Income | $-17M | $-26M | $-52M | $-54M | $124M | $-81M | |
| Income Tax | $0 | $0 | $0 | $0 | $1M | $0 | |
| Net Income | $-17M | $-26M | $-52M | $-54M | $123M | $-81M | |
| EPS (Basic) | · | · | $-0.74 | $-0.77 | $1.78 | $-1.39 | |
| EPS (Diluted) | · | · | $-0.74 | $-0.77 | $1.76 | $-1.39 | |
| Shares (Basic) | · | · | 70,580,604 | 70,424,819 | 67,479,403 | 58,451,293 | |
| Shares (Diluted) | · | · | 70,580,604 | 70,424,819 | 68,067,992 | 58,451,293 | |
| EBITDA | $-42M | · | $-59M | $-55M | $124M | $-81M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $26M | $27M | $45M | $188M | $72M | |
| Prepaid Expense | $5M | $3M | $4M | $2M | $3M | $3M | |
| Current Assets | $74M | $56M | $110M | $131M | $190M | $75M | |
| PP&E (Net) | $252.0K | $433.0K | $769.0K | $1M | $242.8K | $135.6K | |
| Accum. Depreciation | $2M | $1M | $1M | $581.4K | $262.2K | $185.3K | |
| Intangibles | $0 | $100.0K | $200.0K | $222.1K | $164.1K | $319.0K | |
| Other Non-current Assets | $0 | $92.0K | $210.0K | $261.2K | $260.1K | $318.9K | |
| Total Assets | $151M | $92M | $144M | $155M | $195M | $76M | |
| Accounts Payable | $2M | $3M | $4M | $2M | $7M | $5M | |
| Accrued Liabilities | $5M | $6M | $7M | $5M | $8M | $12M | |
| Current Liabilities | $8M | $11M | $11M | $7M | $15M | $22M | |
| Capital Leases | $12M | $13M | $15M | $16M | $0 | · | |
| Total Liabilities | $20M | $24M | $56M | $23M | $15M | $32M | |
| Common Stock | $130.0K | $71.0K | $71.0K | $70.5K | $70.4K | $65.7K | |
| Paid-in Capital | $452M | $372M | $366M | $358M | $351M | · | |
| Retained Earnings | $-322M | $-304M | $-278M | $-226M | $-171M | $-294M | |
| AOCI | $-202.0K | $-35.0K | $1.0K | $-42.2K | $0 | · | |
| Stockholders' Equity | $131M | $68M | $88M | $132M | $180M | $44M | |
| Liabilities + Equity | $151M | $92M | $144M | $155M | $195M | $76M | |
| Shares Outstanding | 130,184,353 | 71,009,866 | 70,691,992 | 70,466,885 | 70,364,912 | 65,743,170 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $273.0K | $613.0K | $568.0K | $512.5K | $237.1K | $306.8K | |
| Stock-based Comp | $5M | $6M | $7M | $7M | $5M | $8M | |
| Deferred Tax | · | · | · | · | · | $6M | |
| Amort. of Intangibles | $100.0K | $200.0K | $100.0K | $193.3K | $160.2K | $247.0K | |
| Other Non-cash | $-26M | · | $-1M | $-8M | $-10M | $16M | |
| Operating Cash Flow | $-38M | $-56M | $-46M | $-55M | $119M | $-52M | |
| CapEx | $0 | $71.0K | $40.0K | $1M | $184.0K | $127.2K | |
| Investing Cash Flow | $-50M | $55M | $-3M | $-88M | $-2M | $35M | |
| Stock Issued | · | · | · | · | $0 | $47M | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $75M | $622.0K | $31M | $180.7K | $904.1K | $47M | |
| Net Change in Cash | $-13M | $-740.0K | · | $-143M | $118M | $30M | |
| Free Cash Flow | $-38M | · | $-46M | $-56M | $118M | $-52M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -585.2% | · | -15134.6% | -3696.4% | 59.6% | -645.4% | |
| Net Margin | -240.1% | · | -13362.2% | -3604.7% | 59.0% | -642.3% | |
| Pretax Margin | -240.1% | · | -13362.2% | -3604.7% | 59.6% | · | |
| EBITDA Margin | -581.4% | · | -14989.5% | -3662.3% | 59.7% | -643.0% | |
| ROA | -14.3% | · | -35.0% | -31.0% | 90.8% | -103.4% | |
| ROE | -18.7% | · | -55.4% | -39.5% | 65.2% | -151.1% | |
| ROIC | -32.5% | · | -67.5% | -42.0% | 68.4% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | · | 9.6 | 18.8 | 12.9 | 3.4 | |
| Quick Ratio | 1.6 | · | 2.4 | 6.4 | 12.7 | 3.3 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 1.5 | 0.2 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.00 | · | $1.24 | $1.88 | $2.55 | $0.66 | |
| Revenue / Share | · | · | $0.01 | $0.02 | $3.06 | · | |
| Cash Flow / Share | · | · | $-0.65 | $-0.78 | $1.74 | · | |
| Cash / Share | $0.10 | · | $0.38 | $0.64 | $2.67 | $1.10 | |
| EPS (TTM) | $-0.41 | $-0.41 | $-0.74 | $-0.77 | $1.76 | $-1.39 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 1181.3% | 44.4% | -73.9% | -99.3% | 1551.6% | · | |
| Revenue CAGR 3Y | 69.0% | -86.1% | -68.6% | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $566.0K | $392.0K | $2M | $208M | $13M | |
| Net Income TTM | $-17M | $-26M | $-52M | $-54M | $123M | $-81M | |
| Market Cap | $212M | · | $228M | $131M | $226M | $152M | |
| P/E | -4.0 | -2.3 | -4.4 | -2.4 | 1.8 | -1.7 | |
| P/S | 29.3 | · | 580.7 | 87.2 | 1.1 | 12.0 | |
| P/B | 1.6 | · | 2.6 | 1.0 | 1.3 | 3.5 | |
| P / Tangible Book | 1.6 | 1.0 | 2.6 | 1.0 | 1.3 | 3.5 | |
| P / Cash Flow | -5.5 | · | -5.0 | -2.4 | 1.9 | -2.9 | |
| P / FCF | -5.5 | · | -5.0 | -2.3 | 1.9 | -2.9 | |
| Earnings Yield | -25.1% | -43.9% | -23.0% | -41.4% | 54.8% | -60.2% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $733.0K | $0 | $718.0K | $132.0K | $6M | $130.0K | $76.0K | $173.0K | $169.0K | $148.0K | $142.0K | $109.0K | $75.0K | $66.0K | $46.3K | $11.1K | |
| R&D Expense | $10M | $11M | $7M | $6M | $6M | $7M | $6M | $8M | $13M | $10M | $11M | $5M | $6M | $7M | $6M | $5M | |
| SG&A Expense | $6M | $7M | $6M | $7M | $5M | $6M | $5M | $6M | $8M | $7M | $8M | $7M | $8M | $8M | $7M | $8M | |
| Operating Expenses | $16M | $18M | $13M | $13M | $11M | $13M | $11M | $13M | $21M | $18M | $18M | $12M | $14M | $15M | $12M | $13M | |
| Operating Income | $-16M | $-18M | $-12M | $-13M | $-5M | $-13M | $-11M | $-13M | $-21M | $-17M | $-18M | $-12M | $-14M | $-15M | $-12M | $-13M | |
| Interest Income | $2M | $737.0K | $848.0K | $303.0K | $384.0K | $491.0K | $650.0K | $947.0K | $991.0K | $1M | · | · | · | · | · | · | |
| Other Non-op | $689.0K | $858.0K | $22M | $365.0K | $389.0K | $2M | $1M | $-780.0K | $29M | $6M | $3M | $776.0K | $2M | $2M | $618.1K | $836.1K | |
| Pretax Income | $-15M | $-17M | $10M | $-12M | $-5M | $-10M | $-9M | $-14M | $9M | $-12M | $-15M | $-11M | $-12M | $-13M | $-12M | $-12M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-50.0K | $0 | |
| Net Income | $-15M | $-17M | $10M | $-12M | $-5M | $-10M | $-9M | $-14M | $9M | $-12M | $-15M | $-11M | $-12M | $-13M | $-12M | $-12M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-0.20 | $0.12 | $-0.17 | · | $-0.16 | $-0.18 | $-0.19 | $-0.16 | $-0.17 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-0.20 | $0.12 | $-0.17 | · | $-0.16 | $-0.18 | $-0.19 | $-0.16 | $-0.17 | |
| Shares (Basic) | · | · | · | · | · | · | · | 70,975,778 | 70,916,471 | 70,716,929 | · | 70,618,609 | 70,534,181 | 70,490,704 | · | 70,430,554 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 70,975,778 | 71,200,798 | 70,716,929 | · | 70,618,609 | 70,534,181 | 70,490,704 | · | 70,430,554 | |
| EBITDA | $-16M | $-18M | · | $-13M | $-5M | $-12M | · | $-13M | $-21M | $-17M | · | $-12M | $-14M | $-15M | · | $-13M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $94M | $13M | $21M | $28M | $21M | $26M | $15M | $30M | $31M | $27M | $57M | $72M | $63M | $45M | $58M | |
| Prepaid Expense | $6M | $5M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $3M | $4M | $5M | $6M | $2M | $2M | $3M | |
| Current Assets | $124M | $160M | $74M | $29M | $42M | $46M | $56M | $66M | $81M | $93M | $110M | $92M | $102M | $120M | $131M | $140M | |
| PP&E (Net) | $201.0K | $217.0K | $252.0K | $269.0K | $285.0K | $346.0K | $433.0K | $509.0K | $618.0K | $686.0K | $769.0K | $856.5K | $955.6K | $1M | $1M | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $899.5K | $795.1K | $689.8K | $581.4K | $449.8K | |
| Intangibles | $0 | $0 | $0 | $0 | $0 | $38.0K | $100.0K | $155.0K | $219.0K | $148.0K | $200.0K | $222.1K | $263.4K | $185.9K | $222.1K | $275.4K | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $39.0K | $92.0K | $182.0K | $246.0K | $174.0K | $210.0K | $248.7K | $290.0K | $212.5K | $261.2K | $275.4K | |
| Total Assets | $232M | $226M | $151M | $64M | $77M | $82M | $92M | $103M | $118M | $132M | $144M | $125M | $136M | $143M | $155M | $165M | |
| Accounts Payable | $4M | $9M | $2M | $2M | $4M | $2M | $3M | $3M | $5M | $4M | $4M | $1M | $4M | $2M | $2M | $1M | |
| Accrued Liabilities | $4M | $5M | $5M | $3M | $3M | $6M | $6M | $8M | $8M | $4M | $7M | $6M | $5M | $4M | $5M | $6M | |
| Current Liabilities | $10M | $16M | $8M | $7M | $9M | $9M | $11M | $12M | $14M | $9M | $11M | $9M | $10M | $7M | $7M | · | |
| Capital Leases | $11M | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $16M | |
| Total Liabilities | $22M | $27M | $20M | $19M | $22M | $22M | $24M | $26M | $29M | $53M | $56M | $24M | $26M | $22M | $23M | $23M | |
| Common Stock | $185.0K | $167.0K | $130.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $70.7K | $70.6K | $70.5K | $70.5K | $70.5K | |
| Paid-in Capital | $564M | $537M | $452M | $376M | $375M | $374M | $372M | $371M | $370M | $368M | $366M | $364M | $362M | $360M | $358M | · | |
| Retained Earnings | $-354M | $-339M | $-322M | $-331M | $-319M | $-315M | $-304M | $-295M | $-281M | $-290M | $-278M | $-263M | $-251M | $-239M | $-226M | $-214M | |
| AOCI | $-750.0K | $-422.0K | $-202.0K | $-126.0K | $-69.0K | $-47.0K | $-35.0K | $36.0K | $-12.0K | $-19.0K | $1.0K | $-3.9K | $5.2K | $5.6K | $-42.2K | $-82.8K | |
| Stockholders' Equity | $210M | $198M | $131M | $45M | $56M | $59M | $68M | $76M | $89M | $78M | $88M | $101M | $111M | $121M | $132M | $142M | |
| Liabilities + Equity | $232M | $226M | $151M | $64M | $77M | $82M | $92M | $103M | $118M | $132M | $144M | $125M | $136M | $143M | $155M | $165M | |
| Shares Outstanding | 184,755,735 | 167,266,466 | 130,184,353 | 71,151,981 | 71,109,514 | 71,109,514 | 71,009,866 | 71,009,866 | 70,971,577 | 70,783,961 | 70,691,992 | 70,680,551 | 70,602,793 | 70,491,510 | 70,466,885 | 70,466,885 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16.0K | $35.0K | $17.0K | $16.0K | $99.0K | $141.0K | $160.0K | $169.0K | $148.0K | $136.0K | $140.0K | $145.9K | $137.3K | $145.0K | $185.0K | $155.4K | |
| Stock-based Comp | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Amort. of Intangibles | $0 | $0 | $9.0K | $0 | $38.0K | $53.0K | $56.0K | $64.0K | $45.0K | $35.0K | $-9.0K | $41.0K | $32.0K | $36.0K | $75.8K | $53.3K | |
| Other Non-cash | · | $2M | · | · | · | $-1M | · | · | · | $-7M | · | · | · | $-817.2K | · | · | |
| Operating Cash Flow | $-18M | $-14M | $-10M | $-13M | $-5M | $-10M | $-10M | $-15M | $-14M | $-17M | $-12M | $-10M | $-12M | $-12M | $-9M | $-13M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $22.0K | $-4.0K | $34.0K | $19.0K | $13.0K | $5.6K | $7.4K | $14.0K | $119.9K | $18.6K | |
| Investing Cash Flow | $-87M | $6M | $-72M | $5M | $12M | $5M | $21M | $292.0K | $13M | $20M | $-49M | $-4M | $20M | $30M | $-4M | $-2M | |
| Stock Issued | $1.0K | $2M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $22M | $89M | $75M | $15.0K | $0 | $13.0K | $0 | $38.0K | $356.0K | $228.0K | $30M | $223.9K | $211.0K | $67.0K | $-43.6K | $81.6K | |
| Net Change in Cash | $-83M | $81M | · | · | $7M | $-5M | · | · | · | · | · | · | · | · | · | $-15M | |
| Free Cash Flow | · | · | · | · | · | $-10M | · | · | · | $-17M | · | · | · | $-12M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2141.6% | · | · | -9487.1% | -80.9% | -9653.9% | · | -7645.1% | -12140.2% | -11768.2% | · | -11038.5% | -18896.0% | -22509.5% | · | -115329.3% | |
| Net Margin | -2047.6% | · | · | -9210.6% | -74.7% | -7873.1% | · | -8096.0% | 5042.0% | -7901.3% | · | -10325.9% | -16544.4% | -20187.7% | · | -107798.3% | |
| Pretax Margin | -2047.6% | · | · | -9210.6% | -74.7% | -7873.1% | · | -8096.0% | 5042.0% | -7901.3% | · | -10325.9% | -16544.4% | -20187.7% | · | -107798.3% | |
| EBITDA Margin | -2141.6% | · | · | -9487.1% | -80.9% | -9545.4% | · | -7645.1% | -12140.2% | -11676.3% | · | -11038.5% | -18896.0% | -22290.9% | · | -115329.3% | |
| ROA | -9.7% | -11.1% | · | -14.6% | -4.8% | -9.6% | · | -12.3% | 6.7% | -8.5% | · | -7.8% | -7.9% | -8.0% | · | -6.4% | |
| ROE | -11.3% | -13.2% | · | -20.1% | -6.5% | -14.9% | · | -15.8% | 8.5% | -11.7% | · | -9.2% | -9.4% | -9.3% | · | -7.1% | |
| ROIC | -7.5% | -9.0% | · | -28.0% | -9.1% | -21.2% | · | -17.3% | -23.1% | -22.2% | · | -11.9% | -12.8% | -12.3% | · | -9.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.4 | 10.2 | · | 4.2 | 4.7 | 4.9 | · | 5.7 | 5.7 | 10.5 | · | 10.6 | 10.1 | 17.8 | · | · | |
| Quick Ratio | 1.1 | 6.0 | · | 3.0 | 3.2 | 2.3 | · | 1.3 | 2.1 | 3.5 | · | 6.6 | 7.1 | 9.4 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.14 | $1.19 | · | $0.63 | $0.78 | $0.83 | · | $1.07 | $1.25 | $1.11 | · | $1.43 | $1.57 | $1.72 | · | $2.02 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.24 | · | · | · | $-0.17 | · | · | |
| Cash / Share | $0.06 | $0.56 | · | $0.29 | $0.40 | $0.30 | · | $0.21 | $0.42 | $0.43 | · | $0.81 | $1.01 | $0.89 | · | $0.83 | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | $-0.69 | $-0.70 | $-0.73 | · | $-0.98 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $7M | · | $7M | $7M | $548.0K | · | $632.0K | $568.0K | $474.0K | · | $296.3K | $198.4K | $123.4K | · | $1M | |
| Net Income TTM | $-34M | $-24M | · | $-36M | $-38M | $-25M | · | $-33M | $-30M | $-51M | · | $-49M | $-49M | $-51M | · | $-69M | |
| Market Cap | $497M | $371M | · | $92M | $23M | $22M | · | $84M | $55M | $216M | · | $271M | $232M | $182M | · | $130M | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | -5.6 | -4.7 | -3.5 | · | -1.9 | |
| P/S | 314.0 | 52.1 | · | 14.0 | 3.5 | 40.5 | · | 132.6 | 96.1 | 455.5 | · | 916.1 | 1167.3 | 1474.0 | · | 89.0 | |
| P/B | 2.4 | 1.9 | · | 2.1 | 0.4 | 0.4 | · | 1.1 | 0.6 | 2.8 | · | 2.7 | 2.1 | 1.5 | · | 0.9 | |
| P / Tangible Book | 2.4 | 1.9 | · | 2.1 | 0.4 | 0.4 | · | 1.1 | 0.6 | 2.8 | · | 2.7 | 2.1 | 1.5 | · | 0.9 | |
| P / Cash Flow | · | -26.7 | · | · | · | -2.2 | · | · | · | -12.9 | · | · | · | -15.0 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | -18.0% | -21.3% | -28.3% | · | -53.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $7M | $566.0K | $392.0K | $2M | $208M |
| Betriebsgewinnmarge % | -585.2% | · | -15134.6% | -3696.4% | 59.6% |
| Nettoergebnis | $-17M | $-26M | $-52M | $-54M | $123M |
| Verwässerte EPS | · | · | $-0.74 | $-0.77 | $1.76 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 9.0 | · | 9.6 | 18.8 | 12.9 |
| Quick Ratio | 1.6 | · | 2.4 | 6.4 | 12.7 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-38M | · | $-46M | $-56M | $118M |
Institutionelle Eigentümer (13F) 142 Einreicher · $378.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
142
Gehaltener Wert
$378.9M
Neue Positionen
46
Geschlossene Positionen
17
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 46 (+15 vs. Vorquartal) | 17 (+9 vs. Vorquartal) | 34 (-1 vs. Vorquartal) | 29 (+8 vs. Vorquartal) | +21.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | $31.774.928 | 11.812.241 | 8,39% | Aktien |
| BlackRock, Inc. | $29.115.162 | 10.823.480 | 7,68% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $28.247.604 | 10.500.968 | 7,45% | Aktien |
| Affinity Asset Advisors, LLC | $27.288.872 | 10.144.562 | 7,20% | Aktien |
| JANUS HENDERSON GROUP PLC | $23.731.510 | 10.714.000 | 6,26% | Aktien |
| STATE STREET CORP | $21.253.058 | 7.900.765 | 5,61% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $20.874.707 | 7.760.114 | 5,51% | Aktien |
| ADAR1 Capital Management, LLC | $19.953.019 | 7.417.479 | 5,27% | Aktien |
| Balyasny Asset Management L.P. | $18.074.314 | 6.719.076 | 4,77% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $16.580.571 | 6.163.781 | 4,38% | Aktien |
| FEDERATED HERMES, INC. | $16.009.982 | 5.951.666 | 4,23% | Aktien |
| BRAIDWELL LP | $15.923.358 | 5.919.464 | 4,20% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $10.957.549 | 4.072.653 | 2,89% | Aktien |
| TAKEDA PHARMACEUTICAL CO LTD | $9.791.595 | 7.531.996 | 2,58% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8.342.037 | 3.101.129 | 2,20% | Aktien |
| STEMPOINT CAPITAL LP | $6.502.491 | 2.417.283 | 1,72% | Aktien |
| Ikarian Capital, LLC | $6.105.503 | 2.269.704 | 1,61% | Aktien |
| Point72 Asset Management, L.P. | $5.234.006 | 1.945.727 | 1,38% | Aktien |
| VANGUARD GROUP INC | $5.007.730 | 3.072.227 | 1,32% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $3.639.570 | 1.353.000 | 0,96% | Aktien |
| NORTHERN TRUST CORP | $3.352.114 | 1.246.139 | 0,88% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $3.068.626 | 1.140.753 | 0,81% | Aktien |
| Propel Bio Management, LLC | $3.000.797 | 1.115.538 | 0,79% | Aktien |
| Rosalind Advisors, Inc. | $2.980.504 | 1.107.994 | 0,79% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.773.237 | 1.030.943 | 0,73% | Aktien |
| Sio Capital Management, LLC | $2.704.348 | 1.005.334 | 0,71% | Aktien |
| Ensign Peak Advisors, Inc | $2.657.946 | 988.084 | 0,70% | Aktien |
| Nuveen, LLC | $2.402.853 | 893.254 | 0,63% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.239.097 | 832.378 | 0,59% | Aktien |
| WELLS FARGO & COMPANY/MN | $2.222.494 | 826.206 | 0,59% | Aktien |
| ORBIMED ADVISORS LLC | $2.009.430 | 747.000 | 0,53% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.984.569 | 737.758 | 0,52% | Aktien |
| Saturn V Capital Management LP | $1.783.631 | 663.060 | 0,47% | Aktien |
| Ally Bridge Group (NY) LLC | $1.680.069 | 624.561 | 0,44% | Aktien |
| UBS Group AG | $1.234.487 | 458.917 | 0,33% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.194.473 | 444.042 | 0,32% | Aktien |
| Bank of New York Mellon Corp | $1.119.897 | 416.318 | 0,30% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.101.528 | 409.490 | 0,29% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.043.445 | 387.767 | 0,28% | Aktien |
| GOLDMAN SACHS GROUP INC | $894.942 | 332.692 | 0,24% | Aktien |
| Informed Momentum Co LLC | $698.407 | 259.631 | 0,18% | Aktien |
| Atom Investors LP | $677.439 | 251.836 | 0,18% | Aktien |
| CIBC WORLD MARKET INC. | $588.709 | 218.851 | 0,16% | Aktien |
| Parkman Healthcare Partners LLC | $532.477 | 197.947 | 0,14% | Aktien |
| SEI INVESTMENTS CO | $529.083 | 196.685 | 0,14% | Aktien |
| CITIGROUP INC | $513.946 | 191.058 | 0,14% | Aktien |
| Invesco Ltd. | $470.481 | 174.900 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $457.666 | 170.139 | 0,12% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $455.638 | 169.382 | 0,12% | Aktien |
| DEUTSCHE BANK AG\ | $401.862 | 149.391 | 0,11% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Mark Feldberg, TLS Advisors LLC, Shira Capital LLC, TradeLink Securities LLC, Tripletail Capital Management LP ×5 Einreichungen | 27. Mai 2020 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 20 Insider · 9 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Margaret A. Alexander | President and CEO | 26. Februar 2026 A | 61.750 | 0 | 1 | $-16.901 |
| Charles Ross Carter | Chief Financial Officer | 6. Juli 2026 A | 94.375 | 0 | 0 | $0 |
| Yaron Werber | CBO, CFO, Sec. and Treas. | 19. Januar 2018 A | · | 0 | 0 | $0 |
| Amit Rakhit | President and CMO | 14. Juli 2021 M | 726.823 | 0 | 0 | $0 |
| Jason Tardio | Chief Operating Officer | 22. Februar 2024 A | 28.125 | 0 | 0 | $0 |
| Thomas Michael Perone | General Counsel, Secretary | 22. Februar 2024 A | 28.125 | 0 | 0 | $0 |
| Dirk Haasner | SVP, Global Regulatory Affairs | 17. Dezember 2020 A | · | 0 | 0 | $0 |
| Timothy Daly | EVP,Finance & Corp. Controller | 17. Dezember 2020 A | · | 0 | 0 | $0 |
| Ana Ward | SVP and General Counsel | 24. Februar 2019 A | · | 0 | 0 | $0 |
| Anna Greka | Direktor | 15. Juni 2026 A | · | 0 | 0 | $0 |
| Kevin Joseph Fitzgerald | Direktor | 7. April 2026 A | 17.578 | 0 | 0 | $0 |
| Stelios Papadopoulos | Direktor | 7. April 2026 A | 217.578 | 0 | 0 | $0 |
| Karen Bernstein | Direktor | 26. Februar 2026 A | 20.000 | 0 | 0 | $0 |
| Robert Michael Poole | Direktor | 22. Februar 2024 A | · | 0 | 0 | $0 |
| Douglas E Williams | Direktor | 17. Mai 2021 A | 5.000 | 0 | 0 | $0 |
| Matthew During | Direktor | 1. April 2019 A | 4.307.314 | 0 | 0 | $0 |
| Bart Friedman | · | 7. April 2026 A | 8.789 | 0 | 0 | $0 |
| Jeremy M Levin | · | 23. März 2026 M | 3.735.048 | 0 | 0 | $0 |
| Barbara Gayle Duncan | · | 26. Februar 2026 A | · | 0 | 0 | $0 |
| Jeffrey A Rona | · | 26. Februar 2026 A | 156.313 | 0 | 1 | $-12.384 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 17 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,46% | 13.036 SH | 11. September 2026 | Täglich |
| IWC · iShares Trust | 0,09% | 516.966 SH | 11. September 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,08% | 167.199 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,02% | 2.284 NS | 31. Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 117.475 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 3.906.782 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 137.815 SH | 2. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 72.842 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.952.040 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 881.326 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,00% | 169.022 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 83.973 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 342.580 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.653.216 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 19.401 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12.741 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 1.268.401 SH | 11. September 2026 | Täglich |
OVID Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 16 Analysten
KAUF
Median-Ziel
$5.00
+110,1%
7 43,8%
Starker Kauf
8 50,0%
Kauf
1 6,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
9 Analysten · 2026-10-01Mittelwert-Ziel $5.92 +148,6%
← Unter allen Zielen
Aktueller Preis $2.38
Tief$4.00
Mittelwert$5.92
Hoch$9.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026